Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results...
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
About this item
Full title
Author / Creator
for the SAKK and the German CML Study Group , Hehlmann, R , Lauseker, M , Saußele, S , Pfirrmann, M , Krause, S , Kolb, H J , Neubauer, A , Hossfeld, D K , Nerl, C , Gratwohl, A , Baerlocher, G M , Heim, D , Brümmendorf, T H , Fabarius, A , Haferlach, C , Schlegelberger, B , Müller, M C , Jeromin, S , Proetel, U , Kohlbrenner, K , Voskanyan, A , Rinaldetti, S , Seifarth, W , Spieß, B , Balleisen, L , Goebeler, M C , Hänel, M , Ho, A , Dengler, J , Falge, C , Kanz, L , Kremers, S , Burchert, A , Kneba, M , Stegelmann, F , Köhne, C A , Lindemann, H W , Waller, C F , Pfreundschuh, M , Spiekermann, K , Berdel, W E , Müller, L , Edinger, M , Mayer, J , Beelen, D W , Bentz, M , Link, H , Hertenstein, B , Fuchs, R , Wernli, M , Schlegel, F , Schlag, R , de Wit, M , Trümper, L , Hebart, H , Hahn, M , Thomalla, J , Scheid, C , Schafhausen, P , Verbeek, W , Eckart, M J , Gassmann, W , Pezzutto, A , Schenk, M , Brossart, P , Geer, T , Bildat, S , Schäfer, E , Hochhaus, A and Hasford, J
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Chronic myeloid leukemia (CML)-study IV was designed to explore whether treatment with imatinib (IM) at 400 mg/day (
n
=400) could be optimized by doubling the dose (
n
=420), adding interferon (IFN) (
n
=430) or cytarabine (
n
=158) or using IM after IFN-failure (
n
=128). From July 2002 to March 2012, 1551 newly diag...
Alternative Titles
Full title
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Authors, Artists and Contributors
Author / Creator
Hehlmann, R
Lauseker, M
Saußele, S
Pfirrmann, M
Krause, S
Kolb, H J
Neubauer, A
Hossfeld, D K
Nerl, C
Gratwohl, A
Baerlocher, G M
Heim, D
Brümmendorf, T H
Fabarius, A
Haferlach, C
Schlegelberger, B
Müller, M C
Jeromin, S
Proetel, U
Kohlbrenner, K
Voskanyan, A
Rinaldetti, S
Seifarth, W
Spieß, B
Balleisen, L
Goebeler, M C
Hänel, M
Ho, A
Dengler, J
Falge, C
Kanz, L
Kremers, S
Burchert, A
Kneba, M
Stegelmann, F
Köhne, C A
Lindemann, H W
Waller, C F
Pfreundschuh, M
Spiekermann, K
Berdel, W E
Müller, L
Edinger, M
Mayer, J
Beelen, D W
Bentz, M
Link, H
Hertenstein, B
Fuchs, R
Wernli, M
Schlegel, F
Schlag, R
de Wit, M
Trümper, L
Hebart, H
Hahn, M
Thomalla, J
Scheid, C
Schafhausen, P
Verbeek, W
Eckart, M J
Gassmann, W
Pezzutto, A
Schenk, M
Brossart, P
Geer, T
Bildat, S
Schäfer, E
Hochhaus, A
Hasford, J
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5668495
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5668495
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2017.253
